Genenta Science S.p.A.
GNTA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001838716
No open-market purchases or sales by Genenta Science S.p.A. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.33M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Genenta Science S.p.A. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 4 | 5 | +1 |
| Shares | 359.7K | 537.3K | +177.6K (+49.4%) |
| Value | $1.42M | $2.10M | +$680.3K (+47.8%) |
New holders (2)
Institutions that held Genenta Science S.p.A. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Morgan Stanley | 3,400 | $13.5K | 0.00% |
| UBS Group AG | 91 | $361 | 0.00% |
Sold out (1)
Institutions that held Genenta Science S.p.A. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Citadel Advisors LLC | 11,167 | $46.5K |